Suven Pharmaceuticals Limited (SUVENPHAR) — Free Cash Flow Generation Index
Suven Pharmaceuticals Limited (SUVENPHAR) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of Rs255.04 Million represents 1% of operating cash flow (Rs255.04 Million). Read SUVENPHAR total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Suven Pharmaceuticals Limited Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Suven Pharmaceuticals Limited across 7 annual periods. Explore Suven Pharmaceuticals Limited (SUVENPHAR) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year Free Cash Flow Generation Index for Suven Pharmaceuticals Limited. For the full company profile including market capitalisation, see Suven Pharmaceuticals Limited market capitalisation.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | Rs1.32 Billion | Rs2.88 Billion | Rs1.56 Billion | ▼ -46.3% |
| 2024 | 0.86x | Rs3.07 Billion | Rs3.58 Billion | Rs517.87 Million | ▲ +133.6% |
| 2023 | 0.37x | Rs1.65 Billion | Rs4.51 Billion | Rs2.86 Billion | ▼ -52.6% |
| 2022 | 0.77x | Rs2.55 Billion | Rs3.30 Billion | Rs751.87 Million | ▲ +8.6% |
| 2021 | 0.71x | Rs2.73 Billion | Rs3.83 Billion | Rs1.11 Billion | ▼ -6.6% |
| 2020 | 0.76x | Rs3.17 Billion | Rs4.16 Billion | Rs994.15 Million | ▲ +701.1% |
| 2019 | -0.13x | Rs-63.81 Million | Rs504.05 Million | Rs567.86 Million | — |